ConductScience.org, home

Paper856015

Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.

Wust J. Antimicrob Agents Chemother, 1977. Cited by 84 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods. Papers, record 856015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/856015

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
84
iCite
Relative citation ratio, by iCite
5.35
iCite
Revised in PubMed
2021-05-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wust JJ

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
MetronidazoleMajor topic
NitroimidazolesMajor topic
OrnidazoleMajor topic
TinidazoleMajor topic
Anaerobiosis
Microbial Sensitivity Tests
Species Specificity

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115830478Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15830478PubMed
215825410Susceptibility of Clostridium ramosum to antimicrobial agents.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15825410PubMed
315825387Proposed standardized method for testing and interpreting susceptibility of Bacteroides fragilis to tetracycline.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15825387PubMed
5984743Susceptibility testing of anaerobic bacteria with 100-microg carbenicillin disks.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984743PubMed
64790595Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790595PubMed
71100592Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis.J Antimicrob Chemother1975https://conductscience.org/library/papers/1100592PubMed
84824012Anaerobic infections. 1.N Engl J Med1974https://conductscience.org/library/papers/4824012PubMed
94140982Inadequate antibody response to HBAg or suppressor T-cell defect in development of active chronic hepatitis.Lancet1974https://conductscience.org/library/papers/4140982PubMed
101270596Inhibition of Bacteroides fragilis on blood agar plates and reversal of inhibition by added hemin.J Clin Microbiol1976https://conductscience.org/library/papers/1270596PubMed
114375789In vitro effect of metronidazole and tinidazole on anaerobic bacteria.Med Microbiol Immunol1974https://conductscience.org/library/papers/4375789PubMed
124372272Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.J Infect Dis1974https://conductscience.org/library/papers/4372272PubMed
134335792The susceptibility of Bacteroides fragilis to 24 antibiotics.J Infect Dis1972https://conductscience.org/library/papers/4335792PubMed
144496865Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis.Scand J Infect Dis1974https://conductscience.org/library/papers/4496865PubMed
154479576Anaerobic septicemia from thrombophlebitis of the internal jugular vein. Successful treatment with metronidazole.JAMA1974https://conductscience.org/library/papers/4479576PubMed
16163867Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli.J Infect Dis1975https://conductscience.org/library/papers/163867PubMed
17171248Antimicrobial agents acting against anaerobes.J Antimicrob Chemother1975https://conductscience.org/library/papers/171248PubMed
18172007Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/172007PubMed
194718964Bactericidal activity of metronidazole against Bacteroides fragilis.J Clin Pathol1973https://conductscience.org/library/papers/4718964PubMed
204680809Standardized single-disc method for antibiotic susceptibility testing of anaerobic bacteria.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4680809PubMed
214680804In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4680804PubMed

See all 32 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
10384859Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.Clin Pharmacokinet1999https://conductscience.org/library/papers/10384859PubMed
7382911Effect of tinidazole on the oral, throat, and colon microflora of man.Med Microbiol Immunol1980https://conductscience.org/library/papers/7382911PubMed
7103447Intravenous metronidazole for treatment of infections involving anaerobic bacteria.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7103447PubMed
7059421Bile and serum levels of tinidazole after a single oral dose.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7059421PubMed
6749473Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy.Drugs1982https://conductscience.org/library/papers/6749473PubMed
6660863Pharmacokinetics of metronidazole in patients undergoing peritoneal dialysis.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6660863PubMed
6341253Tinidazole--microbiology, pharmacology and efficacy in anaerobic infections.Infection1983https://conductscience.org/library/papers/6341253PubMed
6286503[Antibiotic resistance of anaerobic bacteria (author's transl)].Infection1982https://conductscience.org/library/papers/6286503PubMed
4073879
Comparative evaluation of the 2-methyl-5-nitroimidazole compounds dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole, and panidazole against Bacteroides fragilis and other bacteria of the Bacteroides fragilis group.
Antimicrob Agents Chemother1985https://conductscience.org/library/papers/4073879PubMed
3582464Pharmacokinetics of ornidazole in neonates and infants after a single intravenous infusion.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3582464PubMed
3566248Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3566248PubMed
739055Propionibacteria as a cause of shunt and postneurosurgical infections.J Clin Pathol1978https://conductscience.org/library/papers/739055PubMed
718156Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/718156PubMed
708014Susceptibility of anaerobic bacteria to ten antimicrobial agents.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/708014PubMed
363399Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.Drugs1978https://conductscience.org/library/papers/363399PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/856015

GET https://conductscience.org/api/papers/v1/856015/references?page=2